Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2141-V11 Prior to Radical Prostatectomy in Prostate Cancer
NCT06347705Phase 2Recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Mar 2024
- Primary completion
- Mar 2029
- Modality
- Engineered Antibody Formats, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of 2141-V11 in prostate cancer (PCa), sponsored by Memorial Sloan Kettering Cancer Center. Started Mar 2024; status: recruiting.
02
Drugs
2141-V11
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06347705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06347705.